Cargando…

Cost of three models of care for drug-resistant tuberculosis patients in Nigeria

BACKGROUND: Nigeria accounts for a significant proportion of the global drug-resistant tuberculosis (DR-TB) burden, a large proportion of which goes untreated. Different models for managing DR-TB treatment with varying levels of hospitalization are in use across Nigeria, however costing evidence is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bada, Florence O., Okpokoro, Evaezi, Blok, Nick, Meribole, Emmanuel, Dutt, Saswata, Dakum, Patrick, Abimiku, Alash’le, Zwerling, Alice, Kik, Sandra V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327521/ https://www.ncbi.nlm.nih.gov/pubmed/30630429 http://dx.doi.org/10.1186/s12879-018-3636-1

Ejemplares similares

Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria
por: Bada, Florence O., et al.
Publicado: (2020)

Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria
por: Bada, Florence O., et al.
Publicado: (2021)

Development of a prospective cohort of HIV Exposed Sero-Negative (HESN) individuals in Jos Nigeria
por: Osawe, Sophia, et al.
Publicado: (2016)

Diagnostic system strengthening for drug resistant tuberculosis in Nigeria: impact and challenges
por: Aliyu, Gambo, et al.
Publicado: (2017)

Community stakeholder engagement during a vaccine demonstration project in Nigeria: lessons on implementation of the good participatory practice guidelines
por: Folayan, Morenike Oluwatoyin, et al.
Publicado: (2019)

Prevalence and characteristics of metabolic syndrome and its components among adults living with and without HIV in Nigeria: a single-center study
por: Jumare, Jibreel, et al.
Publicado: (2023)

Prevalence of Non-Tuberculous Mycobacterial Infections among Tuberculosis Suspects in Nigeria
por: Aliyu, Gambo, et al.
Publicado: (2013)

Cost-effectiveness of point-of-care digital chest-x-ray in HIV patients with pulmonary mycobacterial infections in Nigeria
por: Aliyu, Gambo, et al.
Publicado: (2014)

Characterisation of HIV-1 Molecular Epidemiology in Nigeria: Origin, Diversity, Demography and Geographic Spread
por: Nazziwa, Jamirah, et al.
Publicado: (2020)

Factors associated with receipt of a timely infant birth dose of hepatitis B vaccine at a tertiary hospital in North-Central Nigeria
por: Bada, Florence O., et al.
Publicado: (2022)

Performance and trend for quality of service in a large HIV/AIDS treatment program in Nigeria
por: Aliyu, Ahmad, et al.
Publicado: (2019)

Missed opportunities for early infant diagnosis of HIV in rural North-Central Nigeria: A cascade analysis from the INSPIRE MoMent study
por: Anaba, Udochisom C., et al.
Publicado: (2019)

Optimising Mycobacterium tuberculosis detection in resource limited settings
por: Alfred, Nwofor, et al.
Publicado: (2014)

A23 Identification of HIV drug resistance mutation patterns using illumina MiSeq next generation sequencing in patients failing second-line boosted protease inhibitor therapy in Nigeria
por: James, Onyemata E., et al.
Publicado: (2017)

Primary Health Care: A Necessity in Developing Countries?
por: Okpokoro, Evaezi
Publicado: (2013)

Mycobacterial Etiology of Pulmonary Tuberculosis and Association with HIV Infection and Multidrug Resistance in Northern Nigeria
por: Aliyu, Gambo, et al.
Publicado: (2013)

Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria
por: Anude, Chuka J, et al.
Publicado: (2013)

Demography and the dual epidemics of tuberculosis and HIV: Analysis of cross-sectional data from Sub-Saharan Africa
por: Aliyu, Gambo, et al.
Publicado: (2018)

Effect of community antiretroviral therapy on treatment outcomes among stable antiretroviral therapy patients in Nigeria: A quasi experimental study
por: Dakum, Patrick, et al.
Publicado: (2021)

Preliminary Report on HIV-1 Vaccine Preparedness in Nigeria: Advantages of Recruiting University Students
por: Edubio, Abigail, et al.
Publicado: (2010)

Prevalence of hypertension among patients aged 50 and older living with human immunodeficiency virus
por: Dakum, Patrick, et al.
Publicado: (2019)

Doing No Harm? Adverse Events in a Nation-Wide Cohort of Patients with Multidrug-Resistant Tuberculosis in Nigeria
por: Avong, Yohanna Kamabi, et al.
Publicado: (2015)

Implementing quality assurance for laboratory-based and point-of-care HIV testing in Nigeria
por: Abubakar, Ado, et al.
Publicado: (2016)

Assuring the quality of diagnostic testing: The future is now
por: Nkengsong, John, et al.
Publicado: (2016)

Patient Retention and Adherence to Antiretrovirals in a Large Antiretroviral Therapy Program in Nigeria: A Longitudinal Analysis for Risk Factors
por: Charurat, Man, et al.
Publicado: (2010)

Prevalence and risk factors for obesity among elderly patients living with HIV/AIDS in a low-resource setting
por: Dakum, Patrick, et al.
Publicado: (2021)

The role of connected diagnostics in strengthening regional, national and continental African disease surveillance
por: Gous, Natasha M., et al.
Publicado: (2018)

Delay in the Provision of Antiretroviral Therapy to HIV-infected TB Patients in Nigeria
por: Odume, B., et al.
Publicado: (2017)

Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria
por: Ndembi, Nicaise, et al.
Publicado: (2020)

Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: A prospective cohort study
por: Avong, Yohanna Kambai, et al.
Publicado: (2018)

Immunity in Nigerian women and the effects of pregnancy and infectious disease exposure on fetal immunity
por: Cairo, Cristiana, et al.
Publicado: (2006)

Ease and equity of access to free DR-TB services in Nigeria- a qualitative analysis of policies, structures and processes
por: Oga-Omenka, Charity, et al.
Publicado: (2020)

Epidemiology and psychosocial assessment of COVID-19 among workers of the Nigeria Centre for Disease Control infected with COVID-19
por: Saleh, Fatima, et al.
Publicado: (2023)

TLR10 Senses HIV-1 Proteins and Significantly Enhances HIV-1 Infection
por: Henrick, Bethany M., et al.
Publicado: (2019)

Understanding spending trends for tuberculosis
por: Zwerling, Alice
Publicado: (2020)

Implementing an intensified mentorship approach towards accelerated medical laboratory accreditation in 10 counties in Kenya
por: Musau, Susan K., et al.
Publicado: (2022)

H3Africa: current perspectives
por: Mulder, Nicola, et al.
Publicado: (2018)

A3 Molecular epidemiology of HIV-1 in Nigeria
por: Nazziwa, J, et al.
Publicado: (2019)

HIV Viral Dynamics of Lopinavir/Ritonavir Monotherapy as Second-Line Treatment: A Prospective, Single-Arm Trial
por: Claassen, Cassidy W., et al.
Publicado: (2019)

Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model
por: Moses, Mark W., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0rbjmkgrji0on0g62h7vfbgn33